bullish
KLBF: Medicine Maker Cashed up on Product Strategy
203 Views28 Sep 2016 13:37
Share price is less volatile, good growth in core profit, and slow asset growth relative to its sector
KLBF’s focus to compete with promotional...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
Rising
A. Stotz Investment Research
Quantamental Investing to beat Benchmarks
Price Chart(Sign Up to Access)
- Sido Muncul: Transforming Family Business into a Shareholder Friendly Listed Entity24 May 2018
- Kalbe Farma - A More Energetic Future but Mind the Drugs - On the Ground in J-Town03 Mar 2018
- KLBF: Healthy Growth for This Pharmaceutical25 May 2017
- KLBF: Medicine Maker Cashed up on Product Strategy28 Sep 2016
x